Pricing Log in Create free account

Atossa Therapeutics, Inc. (ATOS) vs CervoMed Inc. (CRVO)

Atossa Therapeutics, Inc. and CervoMed Inc. are both Biotechnology companies. Atossa Therapeutics, Inc. and CervoMed Inc. are of similar size ($21.9M and $20.2M). CervoMed Inc. grew revenue faster over the last twelve months: −58.9% against −93.7%. Across the 13 metrics below, CervoMed Inc. leads on 7 and Atossa Therapeutics, Inc. on 6.

Valuation

Metric ATOS CRVO Biotechnology median
P/E n/m n/m 10.60
P/S 479.89 3.61 9.40
P/B 0.72 0.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 n/m 0.66
EV/Sales (173.58) 0.62 9.02
Earnings yield (202.89%) (228.37%) (32.88%)
Free cash flow yield (186.04%) (196.71%) (23.13%)

Profitability

Metric ATOS CRVO Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (89.23%) (107.62%) (51.96%)
Return on assets (77.91%) (94.73%) (46.06%)
Return on invested capital (3,918.83%) 0.00% 0.00%

Growth

Metric ATOS CRVO Biotechnology median
Revenue growth (TTM) (93.66%) (58.86%) 6.76%
EPS growth (last fiscal year) (34.73%) (47.52%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATOS CRVO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.69 8.57 4.97
Net debt to EBITDA 1.12 0.74 1.01

Dividend

Metric ATOS CRVO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATOS CRVO Biotechnology median
Market cap 20.16m 21.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack